
Esgedap 5mg Tablet
Marketer
East West Pharma
Salt Composition
Dapagliflozin (5mg)
Overview Esgedap 5mg Tablet
Glimepiride 5mg tablets are prescribed, either independently or alongside other medications, for managing type 2 diabetes. They effectively regulate elevated blood glucose, thus mitigating the risk of severe diabetic complications and contributing to heart disease prevention. These tablets may be consumed with or without food, but consistent daily timing is recommended; dosage is determined by your physician. Discontinuation requires medical consultation, as abrupt cessation can lead to elevated blood sugar and potentially serious consequences such as renal impairment and vision loss. This medication is a component of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects encompass vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. Dehydration is possible; adequate hydration is crucial. Practicing good hygiene minimizes the risk of genital fungal infections. Prior to commencing treatment, disclose any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption during treatment to reduce the likelihood of adverse reactions. Regular blood glucose monitoring is essential throughout the treatment period.
Primary Ingredients of Esgedap 5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Esgedap 5mg Tablet
Managing type 2 diabetes
Major Benefits of Esgedap 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Esgedap tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Esgedap 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Esgedap 5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 5mg Esgedap tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Esgedap 5mg Tablet works:
One tablet of Esgedap 5mg is an antidiabetic drug that lowers blood sugar levels by increasing urinary sugar excretion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Esgedap 5mg Tablet is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Esgedap 5mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Esgedap 5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Individuals with kidney impairment should likely avoid Esgedap 5mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Esgedap 5mg tablets pose no safety concerns for individuals with hepatic impairment. No alteration to the Esgedap 5mg tablet dosage is necessary.
What if you forget to take Esgedap 5mg Tablet :
Should you forget to take your Esgedap 5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Esgedap 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
